Richard Burr actually said...

"Tell me why we should reauthorize user fees for pharmaceuticals and devices when, in the case of devices, the length of time has gone up since we instituted user fees?"

"Is it alarming to you that American companies would choose not to seek American approval for breakthroughs that they have?"

"This committee, as well as one in the House, has the policy responsibilities for the Food and Drug Administration."

"It's a disturbing day when I think that the argument is, provide us more money and we'll do a better job."